Neuronetics
$10.849876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.34 (3.24%) As of 3:33 PM EDT today
+$0.34 (3.24%) Today
Why Robinhood?
You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!
About STIM
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
Employees
140
Headquarters
Malvern, Pennsylvania
Founded
2003
Market Cap
194.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
70.73K
High Today
$11.06
Low Today
$10.51
Open Price
$10.51
Volume
78.67K
52 Week High
$36.88
52 Week Low
$8.90
Collections
Price Paid on Robinhood
46% Lower
Right Now
52 Week Low
$13.26
Average Price Paid
$20.22
52 Week High
$39.39
STIM Earnings
-$30.60
-$20.50
-$10.39
-$0.29
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, Pre-Market